-
Predictors of maintained remission at one year following appendicectomy in ulcerative colitis: post-hoc analysis of the ACCURE trial
Visser, E., Pinkney, T. D., Heuthorst, L., D’Haens, G. R., Bemelman, W. A. & Buskens, C. J., 1 Jul 2025, In: British journal of surgery. 112, 7, znaf137.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative colitis (ACCURE): a pragmatic, open-label, international, randomised trial
The ACCURE Study Group, 1 Jun 2025, In: The Lancet Gastroenterology and Hepatology. 10, 6, p. 550-561 12 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
The impact of advanced medical therapies on time to resection and colorectal cancer outcomes in ulcerative colitis patients undergoing colectomy
Visser, E., Luberto, A., Heuthorst, L., Hompes, R., Vermeire, S. V., D’Haens, G. R., Bemelman, W. A., D’Hoore, A., Bislenghi, G. & Buskens, C. J., 1 Feb 2025, In: Journal of Crohn's and Colitis. 19, 2, jjaf015.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
